| Title: |
Antibiotics for treatment of resistant gram-positive coccal infections. |
| Authors: |
Al-Tatari H; Abdel-Haq N; Chearskul P; Asmar B; Al-Tatari, Hossam; Abdel-Haq, Nahed; Chearskul, Pimpanada; Asmar, Basim |
| Source: |
Indian Journal of Pediatrics; Apr2006, Vol. 73 Issue 4, p323-334, 12p |
| Abstract: |
Vancomycin is considered the workhorse for the treatment of most drug-resistant gram-positive bacterial infections. However, concerns have been raised regarding the increasing rates of vancomycin-resistant enterococci and the clinical shortcomings of vancomycin in the treatment of invasive Staphylococcus aureus infections. Resources have been committed to the development of antimicrobial agents with activity against these organisms. This review will focus on the newer antibacterial agents that have been developed for the treatment of resistant gram-positive pathogens. Included in this review are the agents: quinupristin-dalfopristin, linezolid, daptomycin, telithromycin, and tigecycline. [ABSTRACT FROM AUTHOR] |
| : |
Copyright of Indian Journal of Pediatrics is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |